AccessPak for HIV PEP Expanded with Kaletra and Dupilumab Subcutaneous
Determining the interaction of AccessPak for HIV PEP Expanded with Kaletra and Dupilumab Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emtricitabine / lopinavir / ritonavir / tenofovir
Brand name: AccessPak for HIV PEP Expanded with Kaletra
Synonyms: n.a.
Generic Name: dupilumab
Brand name: Dupixent
Synonyms: Dupilumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- AccessPak for HIV PEP Expanded with Kaletra-Dupixent
- AccessPak for HIV PEP Expanded with Kaletra-Duplex T Topical
- AccessPak for HIV PEP Expanded with Kaletra-Durachol
- AccessPak for HIV PEP Expanded with Kaletra-Duraclon
- AccessPak for HIV PEP Expanded with Kaletra-Duraclon injection
- AccessPak for HIV PEP Expanded with Kaletra-Duraflu
- Dupilumab Subcutaneous-AccessPak for HIV PEP Expanded with Viracept
- Dupilumab Subcutaneous-Accolate
- Dupilumab Subcutaneous-Accretropin
- Dupilumab Subcutaneous-Accucaine
- Dupilumab Subcutaneous-AccuHist Drops
- Dupilumab Subcutaneous-AccuHist PDX Drops